2019新型冠状病毒的基因组特征与流行病学:病毒起源及受体结合启示
系统发育分析显示该病毒与2018年中国舟山采集的两种蝙蝠SARS样冠状病毒亲缘最近(88%同一性),与SARS-CoV约79%、MERS-CoV约50%同一性。同源建模提示其受体结合域结构与SARS-CoV相似,可能结合人血管紧张素转换酶2受体。
要点
- 2019-nCoV与蝙蝠SARS样冠状病毒bat-SL-CoVZC45和bat-SL-CoVZXC21亲缘最近,同一性88%。
- 2019-nCoV与SARS-CoV同一性约79%,与MERS-CoV约50%,属Beta冠状病毒属Sarbecovirus亚属。
- 同源建模提示2019-nCoV可能结合人血管紧张素转换酶2受体。
核心结论
- 2019-nCoV与SARS-CoV差异足够大,应视为新的人类感染性β冠状病毒。
- 系统发育分析提示蝙蝠可能是原始宿主,武汉海鲜市场销售动物可能是中间宿主。
- 结构分析提示2019-nCoV可能结合人血管紧张素转换酶2受体。
研究设计与样本
- 对9例住院患者的支气管肺泡灌洗液和培养分离株进行二代测序,其中8例曾到访武汉华南海鲜市场。
- 用Sanger测序连接病毒重叠群获得全长基因组,末端区域用cDNA末端快速扩增确定。
- 对2019-nCoV基因组与其他冠状病毒进行系统发育分析,并用同源建模探索受体结合特性。
主要发现
- 2019-nCoV与2018年中国舟山采集的bat-SL-CoVZC45和bat-SL-CoVZXC21同一性为88%。
- 2019-nCoV与SARS-CoV同一性约79%,与MERS-CoV同一性约50%。
- 系统发育分析显示2019-nCoV属于Beta冠状病毒属Sarbecovirus亚属,与SARS-CoV遗传上不同。
- 同源建模显示2019-nCoV受体结合域结构与SARS-CoV相似,尽管部分关键残基存在氨基酸变异。
临床怎么用
- 应将该病毒作为新的人类感染性β冠状病毒进行监测和防控。
- 蝙蝠可能是原始宿主,市场动物可能是中间宿主,需调查动物来源以阻断传播。
- 受体结合域结构提示可能结合人血管紧张素转换酶2受体,可作为药物和疫苗研发靶点。
局限性
- 同源建模仅为结构预测,未提供实验验证的受体结合证据。
- 蝙蝠为原始宿主、市场动物为中间宿主的推断基于系统发育分析,需进一步调查确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In late December, 2019, patients presenting with viral pneumonia due to an unidentified microbial agent were reported in Wuhan, China. A novel coronavirus was subsequently identified as the causative pathogen, provisionally named 2019 novel coronavirus (2019-nCoV). As of Jan 26, 2020, more than 2000 cases of 2019-nCoV infection have been confirmed, most of which involved people living in or visiting Wuhan, and human-to-human transmission has been confirmed. METHODS: We did next-generation sequencing of samples from bronchoalveolar lavage fluid and cultured isolates from nine inpatients, eight of whom had visited the Huanan seafood market in Wuhan. Complete and partial 2019-nCoV genome sequences were obtained from these individuals. Viral contigs were connected using Sanger sequencing to obtain the full-length genomes, with the terminal regions determined by rapid amplification of cDNA ends. Phylogenetic analysis of these 2019-nCoV genomes and those of other coronaviruses was used to determine the evolutionary history of the virus and help infer its likely origin. Homology modelling was done to explore the likely receptor-binding properties of the virus. FINDINGS: The ten genome sequences of 2019-nCoV obtained from the nine patients were extremely similar, exhibiting more than 99·98% sequence identity. Notably, 2019-nCoV was closely related (with 88% identity) to two bat-derived severe acute respiratory syndrome (SARS)-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21, collected in 2018 in Zhoushan, eastern China, but were more distant from SARS-CoV (about 79%) and MERS-CoV (about 50%). Phylogenetic analysis revealed that 2019-nCoV fell within the subgenus Sarbecovirus of the genus Betacoronavirus, with a relatively long branch length to its closest relatives bat-SL-CoVZC45 and bat-SL-CoVZXC21, and was genetically distinct from SARS-CoV. Notably, homology modelling revealed that 2019-nCoV had a similar receptor-binding domain structure to that of SARS-CoV, despite amino acid variation at some key residues. INTERPRETATION: 2019-nCoV is sufficiently divergent from SARS-CoV to be considered a new human-infecting betacoronavirus. Although our phylogenetic analysis suggests that bats might be the original host of this virus, an animal sold at the seafood market in Wuhan might represent an intermediate host facilitating the emergence of the virus in humans. Importantly, structural analysis suggests that 2019-nCoV might be able to bind to the angiotensin-converting enzyme 2 receptor in humans. The future evolution, adaptation, and spread of this virus warrant urgent investigation. FUNDING: National Key Research and Development Program of China, National Major Project for Control and Prevention of Infectious Disease in China, Chinese Academy of Sciences, Shandong First Medical University.
引用
- Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020. PMID: 32007145. doi:10.1016/S0140-6736(20)30251-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。